A global company specializing in life sciences and materials sciences, Royal DSM has won on appeal the opposition proceedings the patent EP1232198, entitled UV Curable Compositions (UV curable compositions), the Board of Appeal of the European Patent Office in Munich, Germany on January 17. This patent, currently assigned to 3D Systems, Inc., has been revoked at European level, enabling the further development of materials in this area.

"We are pleased with the outcome because it encourages innovation in the field of photopolymers for stereolithography. We pursue more ardently than ever our task is to provide the best materials for the industry and to meet the needs of our customers, "said Melissa Hayes , chief commercial officer for DSM Somos.

DSM is committed to lead the industry towards ever higher levels of performance with Somos stereolithography materials, a distinct and unique subset of additive manufacturing. With over 20 years experience in the industry, offering a comprehensive DSM Somos  products that meet a wide range of applications portfolio, and is fully dedicated to the success of the industry today and tomorrow.

Somos is a registered trademark of Royal DSM, a company of international science, active in the fields of health, nutrition and materials. By combining its unique expertise in the areas of Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all its stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in many international markets, such as nutrition and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive industry, paints, electrical and electronics, life protection, alternative energy and biomaterials.